Therefore alternative combination treatment with antimetabolites, at least during the first couple of rounds of therapy, could be a promising treatment option in therapy protocols in ultra high-risk and following relapsed NB where TP53 mutations are more frequently occurring. Here, TP53 is linked to neuroblastoma.